NELTAZ 4.5
Description
- Combines Piperacillin 4 g and Tazobactam 0.5 g for synergistic antibacterial action
- Broad-spectrum activity against gram-positive and gram-negative bacteria
- Effective in treating hospital-acquired infections and severe systemic infections
- Inhibits beta-lactamase enzymes to combat resistant bacterial strains
- Suitable for respiratory, urinary, intra-abdominal, and skin infections
- Administered via IV for rapid onset in critical care situations
- Ideal for use in ICU and post-surgical infections
Composition
PIPRACILLINE-4 GM, TAZOBACTUM- 0.5 GM
Benefits
NELTAZ 4.5 provides rapid and potent antibacterial activity, especially in severe infections that are resistant to conventional antibiotics. Piperacillin attacks bacterial cell walls, while Tazobactam prevents bacterial enzymes from deactivating the antibiotic, ensuring prolonged and effective treatment. This combination helps in faster recovery, minimizes treatment failures, and is well-suited for ICU and post-operative infections. Its broad coverage makes it an essential choice for empirical therapy in critical care settings.
Introduction
NELTAZ 4.5 is a powerful broad-spectrum injectable antibiotic that combines Piperacillin, a penicillin-class antibacterial agent, with Tazobactam, a beta-lactamase inhibitor. This combination is highly effective against a wide range of gram-positive and gram-negative bacteria, including β-lactamase-producing organisms. NELTAZ 4.5 is commonly used in hospitals and clinical settings to treat serious bacterial infections such as respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and septicemia. Its synergistic action enhances antimicrobial efficacy and reduces the risk of resistance.
